🇺🇸 FDA
Patent

US 11857575

Mesenchymal stem cell-derived exosomes and their uses

granted A61KA61K2035/122A61K2035/128

Quick answer

US patent 11857575 (Mesenchymal stem cell-derived exosomes and their uses) held by Takeda Pharmaceutical Company Limited expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2035/122, A61K2035/128, A61K2300/00, A61K31/4439